Preventive Medicine

The European Medicines Agency has recommended Nobivac NXT HCPChFelV for market authorization in the European Union.

A first-of-its-kind FDA approval for canine behavioral conditions, a potential milestone in veterinary vaccine technology, and new research complicating the picture of how H5N1 moves through dairy farm environments.

The oral moxidectin therapy is available over the counter.

Tick risk is no longer seasonal—Susan E. Little, DVM, PhD, DACVM (Parasitology), explains what’s changed and how to protect patients year-round.

Long-duration flea and tick collars can be a valuable, practical component of comprehensive parasite prevention.

The American Heartworm Society has released the results of its latest survey mapping where the parasite's presence is growing, declining, or staying the same.

New webpage offers communication tips as studies show a substantial share of dog and cat owners still harbor concerns about vaccines.

Global survey finds many pets get parasites, yet owners want clearer prevention advice; vets urge year‑round flea, tick and heartworm protection.

UC Davis teams track HPAI H5N1 in northern elephant seals at Año Nuevo State Park, revealing symptoms, spread, and guidance on preventive measures for visitors.

Pennsylvania boosts HPAI surveillance and biosecurity as avian influenza hits chicken and turkey flocks; USDA testing ramps up to curb spread.

The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.

Christopher Lee, DVM, MPH, DACVPM, DACVM (Parasitology), explains why ticks and other parasites are expanding their range, why year-round isoxazoline use matters, and why indoor pets still face parasite risk.

Jane Sykes, BVSc, PhD, MPH, MBA, FNAP, summarizes the practical parts of the 2023 ACVIM consensus update on leptospirosis and explains what it means for general practice. She covers the biggest shift in recommendations, how to talk to owners about vaccine safety, when to test, and how to handle suspected cases safely in the clinic.

Elanco's monoclonal antibody therapy, Trutect, received a conditional license from the federal agency in 2023.

In a dvm360 interview, Christopher Lee, DVM, MPH, DACVPM, DACVM (Parasitology); Cert: FFC, CFV, RECOVER-ALS, recommends prioritizing epinephrine and species-specific administration to improve patient outcomes.

A concise Q&A for veterinarians summarizing the identification, reporting, treatment, prevention, and practical next steps as the New World screwworm approaches the US border.

"Our research shows that a one-size-fits-all approach to controlling avian pathogenic E coli infections is not effective," said Jai Mehat, BSc, PGCert, PhD, FHEA, coauthor of the study.

The study results place the American foulbrood prevention therapy closer to full USDA licensure.

Zoetis’ Vanguard Recombishield is a nonadjuvanted, recombinant injectable therapy.

Goldstein calls for a shift in veterinary practice from reactive pain treatment to proactive osteoarthritis prevention and lifelong wellness, as National Pet Wellness Month comes to a close.

The therapy from Boehringer Ingelheim provides protection against porcine circovirus type 2.

Dog owners face challenges with heat and disasters, lacking knowledge on heat-related illness and emergency preparedness, making veterinary guidance essential.

New research projects funded to combat avian influenza in swine focus on vaccine development, transmission risks, and biosecurity measures.

Regulatory approval from animal health authorities is still required before the vaccine can be made commercially available.

Plus, the role technicians can play in owner compliance for preventive care